CrossrefInfokarte
Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of response
GastroHep · 2021-03 · 3 (2) · 63-71
DOI: 10.1002/ygh2.444 ↗Abstract
Kein Abstract verfügbar.
EUVIMED